Severe hyponatremia correction, Visual Abstract by Arjun Mohan
Check out the beautiful Visual Abstract for this week’s NephJC by Arjun Mohan.
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
Check out the beautiful Visual Abstract for this week’s NephJC by Arjun Mohan.
Our NephJC NOSTONE editorial in Kidney Medicine is live. Great work from Renz Palisan, Nikita Pawar, and Rasha Alawieh; supported by Swap and Jade.
Read it here.
TenTweetNephJC on X. Natriuresis guidance for intensification of diuretics is one strategy to PUSH decongestion in patient’s with acute heart failure.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) October 5, 2023
Adequate decongestion to prevent rehospitalization & excess mortality are the goals when treating HF. So, why do we fail so often?
This week we look at natriuresis guided diuretic therapy in hospitalized HF patients.
✳️10 tweets #NephJC catch-up ✳️ pic.twitter.com/PjDKcscTOV
Does natriuresis-guided diuretic therapy in patients with acute heart failure improve clinical outcomes?
NSMC Intern Sameen Aamer answers it with a VA
TenTweetNephJC on AIN = TenXNephJC on AIN = XXNephJC on AIN…? Twitter not being called twitter is confusing.
Welcome👋to #TenTweetNephJC!
— Nephrology Journal Club (@NephJC) September 28, 2023
"We seek it here,we seek it there.."
Aye,we nephrologists seek it everywhere.
Couple of weeks ago, NephJC discussed the intriguing urinary biomarker study for diagnosis of AIN by @dmoledina et al.
✳️#NephJC catch-up✳️of the damned, elusive chase!👇 pic.twitter.com/OsiMjOaKEA
The kidney cell architecture atlas infographic by Dr Jithu Kurian
Intensive blood pressure control in hospitalized older adults beneficial or detrimental?
NSMC intern Melvin Chan explains with a visual abstract
Patients are given a lot of fluid post-transplant, but which to choose? Catch up on the latest evidence here.
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) August 4, 2023
✳️10 tweets #NephJC catch-up ✳️
One of kidney transplantation's 1st & greatest challenges is delayed graft function (DGF) - 20-30%. In postop, trembling, weak evidence shows balance could be attained, but no fluid cure
What's BEST (fluid) solution? pic.twitter.com/3ocSa4AmtV
Huge trial on our core work, catch-up here
Welcome to #TenTweetNephJC
— Nephrology Journal Club (@NephJC) July 31, 2023
✳️10 tweets #NephJC catch-up ✳️
🌟Let’s recap the CONVINCE trial which pitted HDF against HD
🌟Do we now have CONVINCE-ing evidence for the superiority of convection added to diffusion? pic.twitter.com/92gW0zKv76
Is intravenous fluid therapy with a balanced crystalloid solution better than saline for patients receiving a deceased donor kidney transplant? Check out the BEST-FLUID VA by NSMC Intern Anitha Swami
Sorry, you missed it.
Purchasing a Golden Flozinator pin will also give you a ticket to the NephJC Live Podcast recording with the Curbsiders at this year’s ASN Kidney Week.